Prof. Moungi Bawendi was selected as one of three recipients of the 2023 Nobel Prize in Chemistry for contributions to the field of quantum dots and nanotechnology, report David Keyton, Mike Corder and Christina Larson for the Associated Press. “The motivation really is the basic science. A basic understanding, the curiosity of how does the world work?” says Bawendi. “And that’s what drives scientists and academic scientists to do what they do.”
Financial Times reporter Clive Cookson spotlights Prof. Moungi Bawendi, one of the recipients of the 2023 Nobel Prize in Chemistry, for his work in the production and advancement of quantum dots. Cookson notes that Bawendi “revolutionized the chemical production of quantum dots, resulting in the development of particles suitable for practical applications.”
Prof. Moungi Bawendi has been named one of three winners of the 2023 Nobel Prize in Chemistry for “the discovery and synthesis of quantum dots, tiny particles that have fueled innovations in nanotechnology from televisions to mapping different tissues in the body,” reports Andrew Joseph for STAT. “Bawendi invented a method for making the dots with high-quality consistency,” explains Joseph.
Prof. Moungi Bawendi has been honored as one of the recipients of this year’s Nobel Prize in Chemistry for his contributions to the discovery and development of quantum dots, reports Emma Bubola and Katrina Miller for The New York Times. Prof. William Tisdale described Bawendi’s prizewinning results as a “key enabling advance, after which the field of quantum dots exploded.”
The 2023 Nobel Prize in Chemistry has been awarded to Prof. Moungi Bawendi, Prof. Louis Brus of Columbia University and Alexei Ekimov of Nanocrystals Technology Inc., for their work in the discovery and development of quantum dots, reports Christian Edwards, Katie Hunt and Ed Upright for CNN. Bawendi “changed the chemical production of quantum dots, resulting in what the [Nobel] committee called ‘almost perfect particles,’” they write. “This development allowed dots to be used in applications.”
Science reporter Daniel Clery spotlights Prof. Moungi Bawendi, one of the winners of the 2023 Nobel Prize in Chemistry for his contributions to the advancement of quantum dots. “The process devised by Bawendi’s team led to the wide commercialization of quantum dots, with many companies competing to produce nanocrystals cheaply,” writes Clery.
Prof. Moungi Bawendi has been awarded the 2023 Nobel Prize in Chemistry for “fundamental discoveries in nanotechnology, particles once considered impossibly small to make,” reports Mark Johnson for The Washington Post. “In 1993, Moungi revolutionized the process, devising a way to create ‘seed,’ or beginner particles that could then be carefully controlled using temperature,” writes Johnson. “The method allowed him to stop the process to achieve particles of just the right size and quality.”
Prof. Moungi Bawendi has been named one of the winners of the 2023 Nobel Prize in Chemistry for his contributions to the study and development of quantum dots, “tiny molecules that interact with light in unusual ways,” reports Katharine Sanderson for Nature. “I didn’t think it would be me that would get this prize because we’re all working together on this,” says Bawendi. “There’s still a lot of exciting work to be done in this field.”
Prof. Moungi Bawendi, Prof. Louis Brus of Columbia University and Alexei Ekimov of Nanocrystals Technology Inc., have been awarded the 2023 Nobel Prize in Chemistry for their work in the development of quantum dots, which are “now used to create color in flat screens, light emitting diode (LED) lamps and devices that help surgeons see blood vessels in tumors,” reports Niklas Pollard and Ludwig Burger for Reuters. “In 1993, Bawendi revolutionized the production of quantum dots, made up of clusters ranging from a few hundred to a few thousand atoms,” writes Pollard and Burger.
Prof. Emerita Evelyn Fox Keller, who was known for her work as a “theoretical physicist, a mathematical biologist and, beginning in the late 1970s, a feminist theorist who explored the way gender pervades and distorts scientific inquiry,” has died, reports Clay Risen for The New York Times. “Keller trained as a physicist and focused much of her early work on applying mathematical concepts to biology,” writes Risen. “But as the feminist movement took hold, she began to think critically about how ideas of masculinity and femininity had affected her profession.”
Prof. Thomas Kochan and Prof. Thomas Malone speak with Boston Globe reporter Hiawatha Bray about the recent deal between the Writers Guild of America and the Alliance of Motion Picture and Television Producers, which will “protect movie screenwriters from losing their jobs to computers that could use artificial intelligence to generate screenplays.” Kochan notes that when it comes to AI, “where workers don’t have a voice through a union, most companies are not engaging their workers on these issues, and the workers have no rights, no redress.”
Michael Bergren, director of MIT’s Undergraduate Research Opportunities Program, speaks with U.S. News & World Report reporter Katie Rix about research opportunities for undergraduates at MIT.
William Pounds, the former dean of the MIT Sloan School of Management who was “famous for being willing to approach and talk to anybody,” has died at age 95. “As an administrator, he wanted to guide business school graduates to become able leaders of corporations like the ones where he had worked," writes Bryan Marquard for The Boston Globe.
STAT reporter Annalisa Merelli writes that the 2023 Lasker Award has been given to Prof. James Fujimoto, research affiliate Eric Swanson SM ’84 and David Huang PhD ’93 for their work advancing the diagnosis of eye disease. Fujimoto, Swanson and Huang developed “optical coherence tomography (OCT) — the first noninvasive technology allowing doctors to see high-resolution images of the retina.”
Prof. James Fujimoto, research affiliate Eric Swanson SM ’84 and David Huang PhD ’93 have won a Lasker Award for their work inventing optical coherence tomography, which can “detect conditions like macular degeneration and diabetic retinopathy earlier than previous methods, preventing blindness,” reports Noah Weiland and Cade Metz for The New York Times. “O.C.T. now is commonly used in ophthalmology offices, where the patient simply rests a chin and forehead against an instrument for a brief scan,” write Weiland and Metz. “The method, invented in 1991, offers a staggering amount of detail about the retina.”